{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,20]],"date-time":"2026-09-20T13:52:50Z","timestamp":1789912370208,"version":"4.0.1"},"reference-count":45,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"vor","delay-in-days":366,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["mp.uscap.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Modern Pathology"],"published-print":{"date-parts":[[2023,11]]},"DOI":"10.1016\/j.modpat.2023.100294","type":"journal-article","created":{"date-parts":[[2023,7,31]],"date-time":"2023-07-31T01:49:55Z","timestamp":1690768195000},"page":"100294","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"title":["ROS1 Alterations as a Potential Driver of Gliomas in Infant, Pediatric, and Adult Patients"],"prefix":"10.1016","volume":"36","author":[{"given":"David M.","family":"Meredith","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linda D.","family":"Cooley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adrian","family":"Dubuc","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer","family":"Morrissette","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robyn T.","family":"Sussman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"MacLean P.","family":"Nasrallah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pamela","family":"Rathbun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kai Lee","family":"Yap","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nitin","family":"Wadhwani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liming","family":"Bao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daynna J.","family":"Wolff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristiane","family":"Ida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Madina","family":"Sukhanova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Craig","family":"Horbinski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lawrence J.","family":"Jennings","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Midhat","family":"Farooqi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melissa","family":"Gener","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin","family":"Ginn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kwok Ling","family":"Kam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koji","family":"Sasaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rashmi","family":"Kanagal-Shamanna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sanda","family":"Alexandrescu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Brat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4037-9284","authenticated-orcid":false,"given":"Xinyan","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.modpat.2023.100294_bib1","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.1016\/j.cell.2007.11.025","article-title":"Global survey of phosphotyrosine signaling identifies oncogenic kinases in lung cancer","volume":"131","author":"Rikova","year":"2007","journal-title":"Cell"},{"issue":"24","key":"10.1016\/j.modpat.2023.100294_bib2","doi-asserted-by":"crossref","first-page":"9270","DOI":"10.1073\/pnas.84.24.9270","article-title":"Expression and rearrangement of the ROS1 gene in human glioblastoma cells","volume":"84","author":"Birchmeier","year":"1987","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"10.1016\/j.modpat.2023.100294_bib3","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1002\/gcc.10207","article-title":"Fusion of FIG to the receptor tyrosine kinase ROS in a glioblastoma with an interstitial del(6)(q21q21)","volume":"37","author":"Charest","year":"2003","journal-title":"Genes Chromosomes Cancer"},{"issue":"8","key":"10.1016\/j.modpat.2023.100294_bib4","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1200\/JCO.2011.35.6345","article-title":"ROS1 rearrangements define a unique molecular class of lung cancers","volume":"30","author":"Bergethon","year":"2012","journal-title":"J\u00a0Clin Oncol"},{"issue":"12","key":"10.1016\/j.modpat.2023.100294_bib5","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0028250","article-title":"Chromosome 3 anomalies investigated by genome wide SNP analysis of benign, low malignant potential and low grade ovarian serous tumours","volume":"6","author":"Birch","year":"2011","journal-title":"PLoS One"},{"issue":"4","key":"10.1016\/j.modpat.2023.100294_bib6","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1002\/hep.26890","article-title":"Fibroblast growth factor receptor 2 tyrosine kinase fusions define a unique molecular subtype of cholangiocarcinoma","volume":"59","author":"Arai","year":"2014","journal-title":"Hepatology"},{"issue":"12","key":"10.1016\/j.modpat.2023.100294_bib7","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1002\/gcc.22212","article-title":"Screening for the FIG-ROS1 fusion in biliary tract carcinomas by nested PCR","volume":"53","author":"Peraldo Neia","year":"2014","journal-title":"Genes Chromosomes Cancer"},{"issue":"3","key":"10.1016\/j.modpat.2023.100294_bib8","doi-asserted-by":"crossref","first-page":"661","DOI":"10.3892\/ijmm.2014.1823","article-title":"Downregulation of ROS-FIG inhibits cell proliferation, colony-formation, cell cycle progression, migration and invasion, while inducing apoptosis in intrahepatic cholangiocarcinoma cells","volume":"34","author":"Deng","year":"2014","journal-title":"Int J Mol Med"},{"issue":"24","key":"10.1016\/j.modpat.2023.100294_bib9","doi-asserted-by":"crossref","first-page":"6471","DOI":"10.1158\/1078-0432.CCR-18-1052","article-title":"Rare but recurrent ROS1 fusions resulting from chromosome 6q22 microdeletions are targetable oncogenes in glioma","volume":"24","author":"Davare","year":"2018","journal-title":"Clin Cancer Res"},{"issue":"12","key":"10.1016\/j.modpat.2023.100294_bib10","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1093\/jnen\/nlz093","article-title":"GOPC-ROS1 fusion due to microdeletion at 6q22 is an oncogenic driver in a subset of pediatric gliomas and glioneuronal tumors","volume":"78","author":"Richardson","year":"2019","journal-title":"J\u00a0Neuropathol Exp Neurol"},{"issue":"8","key":"10.1016\/j.modpat.2023.100294_bib11","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1177\/1066896917727349","article-title":"Clinical application of whole genome array improves the diagnosis of pediatric brain tumors","volume":"25","author":"Shao","year":"2017","journal-title":"Int J Surg Pathol"},{"issue":"1","key":"10.1016\/j.modpat.2023.100294_bib12","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0228356","article-title":"Clinical management and genomic profiling of pediatric low-grade gliomas in Saudi Arabia","volume":"15","author":"Mobark","year":"2020","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.modpat.2023.100294_bib13","doi-asserted-by":"crossref","first-page":"51","DOI":"10.3171\/2017.2.PEDS16679","article-title":"Novel GOPC(FIG)-ROS1 fusion in a pediatric high-grade glioma survivor","volume":"20","author":"Kiehna","year":"2017","journal-title":"J\u00a0Neurosurg Pediatr"},{"issue":"4","key":"10.1016\/j.modpat.2023.100294_bib14","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1016\/j.ccell.2020.03.011","article-title":"Integrated molecular and clinical analysis of 1,000 pediatric low-grade gliomas","volume":"37","author":"Ryall","year":"2020","journal-title":"Cancer Cell"},{"issue":"4","key":"10.1016\/j.modpat.2023.100294_bib15","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1016\/j.ccell.2017.08.017","article-title":"Integrated molecular meta-analysis of 1,000 pediatric high-grade and diffuse intrinsic pontine glioma","volume":"32","author":"Mackay","year":"2017","journal-title":"Cancer Cell"},{"key":"10.1016\/j.modpat.2023.100294_bib16","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.phrs.2017.04.022","article-title":"ROS1 protein-tyrosine kinase inhibitors in the treatment of ROS1 fusion protein-driven non-small cell lung cancers","volume":"121","author":"Roskoski","year":"2017","journal-title":"Pharmacol Res"},{"issue":"11","key":"10.1016\/j.modpat.2023.100294_bib17","doi-asserted-by":"crossref","first-page":"1611","DOI":"10.1016\/j.jtho.2017.08.002","article-title":"Recent advances in targeting ROS1 in lung cancer","volume":"12","author":"Lin","year":"2017","journal-title":"J\u00a0Thorac Oncol"},{"issue":"5","key":"10.1016\/j.modpat.2023.100294_bib18","doi-asserted-by":"crossref","first-page":"3268","DOI":"10.3390\/curroncol28050284","article-title":"Reflex ROS1 IHC screening with FISH confirmation for advanced non-small cell lung cancer-a cost-efficient strategy in a public healthcare system","volume":"28","author":"Makarem","year":"2021","journal-title":"Curr Oncol"},{"key":"10.1016\/j.modpat.2023.100294_bib19","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.cancergen.2020.02.004","article-title":"Copy number assessment in the genomic analysis of CNS neoplasia: an evidence-based review from the cancer genomics consortium (CGC) working group on primary CNS tumors","volume":"243","author":"Neill","year":"2020","journal-title":"Cancer Genet"},{"issue":"7697","key":"10.1016\/j.modpat.2023.100294_bib20","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1038\/nature26000","article-title":"DNA methylation-based classification of central nervous system tumours","volume":"555","author":"Capper","year":"2018","journal-title":"Nature"},{"issue":"6","key":"10.1016\/j.modpat.2023.100294_bib21","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1007\/s00401-021-02369-1","article-title":"GOPC:ROS1 and other ROS1 fusions represent a rare but recurrent drug target in a variety of glioma types","volume":"142","author":"Sievers","year":"2021","journal-title":"Acta Neuropathol"},{"issue":"8","key":"10.1016\/j.modpat.2023.100294_bib22","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1093\/neuonc\/noab106","article-title":"The 2021 WHO classification of tumors of the central nervous system: a summary","volume":"23","author":"Louis","year":"2021","journal-title":"Neuro Oncol"},{"issue":"1","key":"10.1016\/j.modpat.2023.100294_bib23","doi-asserted-by":"crossref","first-page":"4343","DOI":"10.1038\/s41467-019-12187-5","article-title":"Alterations in ALK\/ROS1\/NTRK\/MET drive a group of infantile hemispheric gliomas","volume":"10","author":"Guerreiro Stucklin","year":"2019","journal-title":"Nat Commun"},{"key":"10.1016\/j.modpat.2023.100294_bib24","series-title":"World Health Organization Classification of Tumours of the Central Nervous System","year":"2021"},{"issue":"6","key":"10.1016\/j.modpat.2023.100294_bib25","doi-asserted-by":"crossref","first-page":"565","DOI":"10.3949\/ccjm.55.6.565","article-title":"Re: nocturnal diaphoresis and coronary artery spasm","volume":"55","author":"Cheng","year":"1988","journal-title":"Cleve Clin J Med"},{"issue":"3","key":"10.1016\/j.modpat.2023.100294_bib26","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/0005-2736(83)90501-1","article-title":"The existence of a highly ordered phase in fully hydrated dilauroylphosphatidylethanolamine","volume":"728","author":"Chang","year":"1983","journal-title":"Biochim Biophys Acta"},{"issue":"6","key":"10.1016\/j.modpat.2023.100294_bib27","doi-asserted-by":"crossref","first-page":"751","DOI":"10.5858\/arpa.2016-0527-OA","article-title":"Validation of OncoPanel: a targeted next-generation sequencing assay for the detection of somatic variants in cancer","volume":"141","author":"Garcia","year":"2017","journal-title":"Arch Pathol Lab Med"},{"issue":"8","key":"10.1016\/j.modpat.2023.100294_bib28","doi-asserted-by":"crossref","first-page":"e813","DOI":"10.1097\/MPH.0000000000001711","article-title":"Oncogenic GOPC-ROS1 fusion identified in a congenital glioblastoma case","volume":"42","author":"Whiteway","year":"2020","journal-title":"J\u00a0Pediatr Hematol Oncol"},{"issue":"4","key":"10.1016\/j.modpat.2023.100294_bib29","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1093\/jnen\/nlz006","article-title":"Clinical and molecular characterization of adult glioblastomas in southern Brazil","volume":"78","author":"Trevisan","year":"2019","journal-title":"J\u00a0Neuropathol Exp Neurol"},{"issue":"1","key":"10.1016\/j.modpat.2023.100294_bib30","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1007\/s10014-018-0330-3","article-title":"Identification of a novel KLC1-ROS1 fusion in a case of pediatric low-grade localized glioma","volume":"36","author":"Nakano","year":"2019","journal-title":"Brain Tumor Pathol"},{"issue":"12","key":"10.1016\/j.modpat.2023.100294_bib31","doi-asserted-by":"crossref","first-page":"1478","DOI":"10.1634\/theoncologist.2017-0242","article-title":"Comprehensive genomic profiling of 282 pediatric low- and high-grade gliomas reveals genomic drivers, tumor mutational burden, and hypermutation signatures","volume":"22","author":"Johnson","year":"2017","journal-title":"Oncologist"},{"issue":"2","key":"10.1016\/j.modpat.2023.100294_bib32","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1007\/s11060-019-03377-8","article-title":"Targetable molecular alterations in congenital glioblastoma","volume":"146","author":"Gilani","year":"2020","journal-title":"J\u00a0Neurooncol"},{"issue":"9","key":"10.1016\/j.modpat.2023.100294_bib33","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1002\/gcc.22369","article-title":"Identification of ZCCHC8 as fusion partner of ROS1 in a case of congenital glioblastoma multiforme with a t(6;12)(q21;q24.3)","volume":"55","author":"Cocc\u00e9","year":"2016","journal-title":"Genes Chromosomes Cancer"},{"issue":"7","key":"10.1016\/j.modpat.2023.100294_bib34","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1158\/2159-8290.CD-19-1030","article-title":"Infant high-grade gliomas comprise multiple subgroups characterized by novel targetable gene fusions and favorable outcomes","volume":"10","author":"Clarke","year":"2020","journal-title":"Cancer Discov"},{"issue":"6","key":"10.1016\/j.modpat.2023.100294_bib35","doi-asserted-by":"crossref","first-page":"711","DOI":"10.21873\/cgp.20354","article-title":"Novel TPR::ROS1 fusion gene activates MAPK, PI3K and JAK\/STAT signaling in an infant-type pediatric glioma","volume":"19","author":"Deland","year":"2022","journal-title":"Cancer Genomics Proteomics"},{"issue":"2","key":"10.1016\/j.modpat.2023.100294_bib36","doi-asserted-by":"crossref","first-page":"372","DOI":"10.3390\/diagnostics12020372","article-title":"Molecular landscape in infant high-grade gliomas: a single center experience","volume":"12","author":"Di Ruscio","year":"2022","journal-title":"Diagnostics (Basel)"},{"issue":"1","key":"10.1016\/j.modpat.2023.100294_bib37","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1186\/s40478-020-00980-z","article-title":"Molecular and clinicopathologic features of gliomas harboring NTRK fusions","volume":"8","author":"Torre","year":"2020","journal-title":"Acta Neuropathol Commun"},{"issue":"5","key":"10.1016\/j.modpat.2023.100294_bib38","doi-asserted-by":"crossref","first-page":"547","DOI":"10.5858\/arpa.2021-0295-CP","article-title":"Molecular biomarker testing for the diagnosis of diffuse gliomas","volume":"146","author":"Brat","year":"2022","journal-title":"Arch Pathol Lab Med"},{"issue":"15","key":"10.1016\/j.modpat.2023.100294_bib39","doi-asserted-by":"crossref","first-page":"4040","DOI":"10.1158\/1078-0432.CCR-12-2851","article-title":"Molecular pathways: ROS1 fusion proteins in cancer","volume":"19","author":"Davies","year":"2013","journal-title":"Clin Cancer Res"},{"issue":"16","key":"10.1016\/j.modpat.2023.100294_bib40","doi-asserted-by":"crossref","first-page":"4449","DOI":"10.1158\/1078-0432.CCR-11-3351","article-title":"Analysis of receptor tyrosine kinase ROS1-positive tumors in non-small cell lung cancer: identification of a FIG-ROS1 fusion","volume":"18","author":"Rimkunas","year":"2012","journal-title":"Clin Cancer Res"},{"issue":"6","key":"10.1016\/j.modpat.2023.100294_bib41","doi-asserted-by":"crossref","first-page":"2180","DOI":"10.1158\/0008-5472.CAN-08-3351","article-title":"Epigenetic regulation of c-ROS receptor tyrosine kinase expression in malignant gliomas","volume":"69","author":"Jun","year":"2009","journal-title":"Cancer Res"},{"issue":"3","key":"10.1016\/j.modpat.2023.100294_bib42","doi-asserted-by":"crossref","first-page":"254","DOI":"10.6004\/jnccn.2021.0013","article-title":"NCCN Guidelines Insights: Non-Small Cell Lung Cancer, Version 2.2021","volume":"19","author":"Ettinger","year":"2021","journal-title":"J\u00a0Natl Compr Canc Netw"},{"issue":"6","key":"10.1016\/j.modpat.2023.100294_bib43","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1093\/neuonc\/noac026","article-title":"Two clinically distinct cases of infant hemispheric glioma carrying ZCCHC8:ROS1","volume":"24","author":"Papusha","year":"2022","journal-title":"Neuro Oncol"},{"key":"10.1016\/j.modpat.2023.100294_bib44","doi-asserted-by":"crossref","first-page":"51","DOI":"10.4137\/CGM.S32801","article-title":"Synergistic effects of crizotinib and temozolomide in experimental FIG-ROS1 fusion-positive glioblastoma","volume":"8","author":"Das","year":"2015","journal-title":"Cancer Growth Metastasis"},{"issue":"8","key":"10.1016\/j.modpat.2023.100294_bib45","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1056\/NEJMc2101264","article-title":"Lorlatinib in a child with ALK-fusion-positive high-grade glioma","volume":"385","author":"Bagchi","year":"2021","journal-title":"N\u00a0Engl J Med"}],"container-title":["Modern Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0893395223001990?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0893395223001990?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T01:24:37Z","timestamp":1760232277000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0893395223001990"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11]]},"references-count":45,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2023,11]]}},"alternative-id":["S0893395223001990"],"URL":"https:\/\/doi.org\/10.1016\/j.modpat.2023.100294","relation":{},"ISSN":["0893-3952"],"issn-type":[{"value":"0893-3952","type":"print"}],"subject":[],"published":{"date-parts":[[2023,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"ROS1 Alterations as a Potential Driver of Gliomas in Infant, Pediatric, and Adult Patients","name":"articletitle","label":"Article Title"},{"value":"Modern Pathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.modpat.2023.100294","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 United States & Canadian Academy of Pathology. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"100294"}}